{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T02:40:22Z","timestamp":1775616022871,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hepatology Rep"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s11901-019-00474-0","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T02:04:00Z","timestamp":1563156240000},"page":"269-273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Bile Duct Injury Due to Drug-Induced Liver Injury"],"prefix":"10.1007","volume":"18","author":[{"given":"Priya","family":"Grewal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"474_CR1","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1053\/j.gastro.2010.04.001","volume":"138","author":"N Chalasani","year":"2010","unstructured":"Chalasani N, Bj\u00f6rnsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology. 2010;138:2246\u201359.","journal-title":"Gastroenterology"},{"key":"474_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2036.2010.04320.x","volume":"32","author":"E Bj\u00f6rnsson","year":"2010","unstructured":"Bj\u00f6rnsson E. Review article: drug-induced liver injury in clinical practice. Aliment Pharmacol Ther. 2010;32:3\u201313.","journal-title":"Aliment Pharmacol Ther"},{"key":"474_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.26709","volume":"59","author":"DE Kleiner","year":"2014","unstructured":"Kleiner DE, Chalasani NP, Lee WM, Fontana RJ, Bonkovsky HL, Watkins PB, et al. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology. 2014;59:661\u201370.","journal-title":"Hepatology"},{"key":"474_CR4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/hep.28967","volume":"65","author":"HL Bonkovsky","year":"2017","unstructured":"\u2022\u2022 Bonkovsky HL, Kleiner DE, Gu J, Odin JA, Russo MW, Navarro VM, et al. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements. Hepatology. 2017;65:1267\u201377 Important clinical and histopathologic description of drug induced vanishing bile duct syndrome and its relatively poor prognosis.","journal-title":"Hepatology"},{"key":"474_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.dld.2015.03.002","volume":"47","author":"HO Gudnason","year":"2015","unstructured":"Gudnason HO, Bjornsson HK, Gardarsdottir M, Thorisson HM, Olafsson S, Bergmann OM, et al. Secondary sclerosing cholangitis in patients with drug-induced liver injury. Dig Liv Dis. 2015;47:502\u20137.","journal-title":"Dig Liv Dis"},{"key":"474_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cgh.2018.06.035","volume":"17","author":"J Ahmad","year":"2019","unstructured":"\u2022\u2022 Ahmad J, Rossi S, Rodgers SK, Ghabril M, Fontana RJ, Stolz A, et al. Sclerosing cholangitis-like changes on magnetic resonance cholangiography in patients with drug induced liver injury. Clin Gastroenterol Hepatol. 2019;17:789\u201390 First study to look at drug-induced sclerosing cholangitis using two expert MRCP readings of MRCP done blinded to clinical data.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"474_CR7","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","volume":"148","author":"N Chalasani","year":"2015","unstructured":"Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148:1340\u201352.","journal-title":"Gastroenterology"},{"key":"474_CR8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.crad.2005.01.006","volume":"60","author":"S Phongkitkarun","year":"2005","unstructured":"Phongkitkarun S, Kobayashi S, Varavithya V, Huang X, Curley SA, Charnsangavej C. Bile duct complications of hepatic arterial infusion chemotherapy evaluated by helical CT. Clin Radiol. 2005;60:700\u20139.","journal-title":"Clin Radiol"},{"key":"474_CR9","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.crad.2006.02.013","volume":"61","author":"K Sandrasegaran","year":"2006","unstructured":"Sandrasegaran K, Alazmi WM, Tann M, Fogel EL, McHenry L, Lehman GA. Chemotherapy-induced sclerosing cholangitis. Clin Radiol. 2006;61:670\u20138.","journal-title":"Clin Radiol"},{"key":"474_CR10","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1007\/s10620-015-3914-3","volume":"60","author":"JL Horsley-Silva","year":"2015","unstructured":"Horsley-Silva JL, Dow EN, Menias CO, Smith ML, Carballido EM, Lindor KD, et al. Docetaxel induced sclerosing cholangitis. Dig Dis Sci. 2015;60:3814\u20136.","journal-title":"Dig Dis Sci"},{"key":"474_CR11","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.cgh.2014.01.041","volume":"12","author":"GL Wong","year":"2014","unstructured":"Wong GL, Tam YH, Ng CF, Chan AW, Choi PC, Chu WC, et al. Liver injury is common among chronic abusers of ketamine. Clin Gastroenterol Hepatol. 2014;12:1759\u201362.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"474_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jhep.2018.03.006","volume":"69","author":"WK Seto","year":"2018","unstructured":"\u2022 Seto WK, Mak SK, Chiu K, Vardhanabhuti V, Wong HF, Leong HT, et al. Magnetic resonance cholangiogram patterns and clinical profiles of ketamine-related cholangiopathy in drug users. J Hepatol. 2018;69:121\u20138 Includes well-documented cases of ketamine cholangiopathy with cases of resolution after drug discontinuance.","journal-title":"J Hepatol"},{"key":"474_CR13","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ajg.2010.485","volume":"106","author":"WK Seto","year":"2011","unstructured":"Seto WK, Ng M, Chan P, Ng IO, Cheung SC, Hung IF, et al. Ketamine-induced cholangiopathy: a case report. Am J Gastroenterol. 2011;106:1004\u20135.","journal-title":"Am J Gastroenterol"},{"key":"474_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/hep.26459","volume":"58","author":"A Turkish","year":"2013","unstructured":"Turkish A, Luo JJ, Lefkowitch JH. Ketamine abuse, biliary tract disease, and secondary sclerosing cholangitis. Hepatology. 2013;58:825\u20137.","journal-title":"Hepatology"},{"key":"474_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0168-8278(90)90143-F","volume":"10","author":"M Parola","year":"1990","unstructured":"Parola M, Cheeseman KH, Biocca ME, Dianzani MU, Slater TF. Biochemical studies on bile duct epithelial cells isolated from rat liver. J Hepatol. 1990;10:341\u20135.","journal-title":"J Hepatol"},{"key":"474_CR16","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/hep.510300619","volume":"30","author":"F Lakehal","year":"1999","unstructured":"Lakehal F, Wendum D, Barbu V, Becquemont L, Poupon R, Balladur P, et al. Phase I and phase II drug metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium. Hepatology. 1999;30:1498\u2013506.","journal-title":"Hepatology"},{"key":"474_CR17","first-page":"1456","volume":"91","author":"CB O'Brien","year":"1996","unstructured":"O'Brien CB, Shields DS, Saul SH, Reddy KR. Drug-induced vanishing bile duct syndrome: response to ursodiol. Am J Gastroenterol. 1996;91:1456\u20137.","journal-title":"Am J Gastroenterol"},{"key":"474_CR18","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.3748\/wjg.v13.45.6087","volume":"13","author":"SS Jakab","year":"2007","unstructured":"Jakab SS, West AB, Meighan DM, Brown RS Jr, Hale WB. Mycophenolate mofetil for drug-induced vanishing bile duct syndrome. World J Gastroenterol. 2007;13:6087\u20139.","journal-title":"World J Gastroenterol"},{"key":"474_CR19","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1097\/MPG.0b013e3182a95951","volume":"57","author":"Y Kawasaki","year":"2013","unstructured":"Kawasaki Y, Matsubara K, Hashimoto K, Tanigawa K, Kage M, Iwata A, et al. Nonsteroidal anti-inflammatory drug-induced vanishing bile duct syndrome treated with plasmapheresis. J Pediatr Gastroenterol Nutr. 2013;57:e30\u20131.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"474_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2016.517","volume":"112","author":"PY Kwo","year":"2017","unstructured":"Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112:18\u201335.","journal-title":"Am J Gastroenterol"},{"key":"474_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jacr.2013.02.020","volume":"10","author":"T Lalani","year":"2013","unstructured":"Lalani T, Couto CA, Rosen MP, Baker ME, Blake MA, Cash BD, et al. ACR appropriateness criteria jaundice. J Am Coll Radiol. 2013;10:402\u20139.","journal-title":"J Am Coll Radiol"}],"container-title":["Current Hepatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11901-019-00474-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11901-019-00474-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11901-019-00474-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T23:16:05Z","timestamp":1594682165000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11901-019-00474-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["474"],"URL":"https:\/\/doi.org\/10.1007\/s11901-019-00474-0","relation":{},"ISSN":["2195-9595"],"issn-type":[{"value":"2195-9595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]},"assertion":[{"value":"15 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Priya Grewal and Jawad Ahmad each declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}